# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 18: Amendment to regulation 43

Extent: E+W+S+N.I.

In regulation 43 (obligations of licence holder), omit—
(a) “, and EU marketing authorisation” in paragraph (5)(a)(ii);
(b) “, EU marketing authorisation” in paragraph (7)(b)(ii)(bb);
(c) paragraph (7)(c)(vii);
(d) paragraph (10);
(e) paragraph (11);
(f) “or EU marketing authorisation holder” in paragraph (13).

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/18 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-18
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.